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Quantification of the stoichiometry of phosphorylation is usually achieved using a mixture of
phosphatase treatment and differential isotopic labeling. Here, we introduce a new approach
to the concomitant determination of absolute protein concentration and the stoichiometry of
phosphorylation at predefined sites. The method exploits QconCAT to quantify levels of
phosphorylated and nonphosphorylated peptide sequences in a phosphoprotein. The non-
phosphorylated sequence is used to determine the absolute protein quantity and serves as a
reference to calculate the extent of phosphorylation at the second peptide. Thus, the
stoichiometry of phosphorylation and the absolute protein concentration can be determined
accurately in a single experiment. (J Am Soc Mass Spectrom 2009, 20, 2211–2220) © 2009
American Society for Mass SpectrometryReversible protein phosphorylation is one of themost important post-translational modifications,regulating signaling in both prokaryotic and
eukaryotic cells. The incorporation of a phosphate
group at specific amino acid side chains is catalyzed by
protein kinases and often induces significant conforma-
tional changes in the substrate protein. These changes
can alter recognition by binding cognates and poten-
tially have profound effects on protein activity [1].
Crucially, it is not only the phosphorylation site loca-
tion, but also the stoichiometry of modification that
determines the effect and extent of changes in protein
function. If the biological pathways that these phospho-
proteins comprise are to be modeled to help understand
these networks and their interactions, it is essential that
the proportion of these proteins that are modified be
assessed, in addition to determining their total quantity.
Although the identification of phosphorylation sites by
mass spectrometry (MS) is becoming routine, this anal-
ysis is usually qualitative [2, 3]. A number of studies
have used the relative signal intensities of the phos-
phorylated peptide and the cognate nonphosphorylated
peptide to infer phosphorylation stoichiometry [2, 4, 5].
However, recent evidence indicates that the introduc-
tion of a negatively charged phosphate group can alter
mass spectrometric response factor to an unpredictable
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cannot be determined by simple comparison of these
signal intensities [6, 7].
There are a number of alternative approaches that
have been used to determine the stoichiometry of
protein phosphorylation. Traditionally, this has in-
volved assessing the amount of 32P incorporation [8, 9],
although expense and safety considerations have re-
duced the attractiveness of radioactive-based methods.
Alternatively, mass spectrometric experiments can be
performed to determine the exact amount of phosphor-
ylated and nonphosphorylated peptides, thereby infer-
ring the stoichiometry of phosphorylation, by addition
of known amounts of synthetic stable isotope-labeled
analogues of both variants [10, 11]. This approach
requires the synthesis and purification of numerous
stable isotope-labeled internal standard peptides in
their phosphorylated and nonphosphorylated forms
[12]. Elucidation of the stoichiometry of phosphoryla-
tion has also been demonstrated using a combination of
stable isotope labeling and alkaline phosphatase treat-
ment [13, 14]. This approach requires the sample of
interest to be divided into two aliquots: one is subjected
to phosphatase treatment and subsequent derivatiza-
tion (e.g., methyl esterification), whereas the second is
subjected only to derivatization, using an isotopically
distinct (esterification) reagent. Mass spectrometric
analysis of the recombined mixture reveals light/heavy
ratios differing from unity for those peptides incorpo-
rating a phosphorylation site; the extent of the discrep-
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approach has been developed where labeling of pro-
teins is performed before digestion, thus avoiding the
variation that can be introduced due to phosphorylation-
dependent changes in the efficiency of proteolysis [15].
Nonetheless, all of these strategies require complete (or
at least reproducible) derivatization and are compro-
mised if enzymatic removal of the phosphate group is
incomplete.
To overcome the potential differences in ionization
efficiency of phosphorylated peptides, large-scale com-
parative studies of changes in the extent of specific
protein phosphorylation has been achieved by the ap-
plication of stable isotope labeling of amino acids in
culture (SILAC), a method of differentially labeling
numerous protein populations during cell culture [16,
17]. However, this approach provides no information
on absolute levels of phosphorylated peptides. Steen et
al. introduced a label-free approach to estimate changes
in phosphorylation stoichiometry in a sample series; in
addition, absolute stoichiometries were estimated based
on the correlation of changes in the signals associated
with phosphorylated tryptic peptides and their non-
phosphorylated counterparts by [18]. The approach
depends on the analysis of a sample series showing
variations in phosphorylation stoichiometry.
Here, we describe a broadly applicable strategy that
enables absolute quantification of proteins concurrently
with a rigorous determination of the phosphorylation
stoichiometry at specific sites. The strategy represents a
development of our previously reported QconCAT
method [19], in which absolute quantification of pro-
teins is achieved using internal standards obtained via
the expression of an artificial protein encoding a con-
catenation of multiple “signature” tryptic peptides [19,
20]. By using, for a single protein, a signature peptide
that incorporates the phosphorylation site of interest and a
second that incorporates no modification site, two quan-
titative values are obtained and the discrepancy defines
the stoichiometry of phosphorylation (Scheme 1). In addi-
tion, we illustrate the use as internal standard of a stable
isotope labeled analog of the nonphosphorylated pro-
tein. In both of these methods, quantification of stoichi-
ometry is based upon the assumption that the diminu-
tion of signal associated with a nonmodified peptide is
due to phosphorylation. We have assessed this assump-
tion by comparing results before and after phosphatase
treatment.
The applicability of these novel approaches is dem-
onstrated by the analysis of sites of autophosphoryla-
tion on the catalytic domain of monopolar spindle 1
(Mps1) protein expressed in E. coli. Mps1 is a mitotic
protein kinase required for the spindle assembly check-
point (SAC) in many organisms including yeast, flies,
zebrafish, frogs, and humans [4, 21]. Autophosphoryla-
tion of Mps1 is required for full activity in vitro with
complex changes in the extent and location of phos-
phorylation known to be responsible for regulating
protein kinase function [4, 21]. We previously identified16 sites of autophosphorylation using liquid chroma-
tography (LC)-MS/MS, incorporating the complemen-
tary fragmentation strategies of collision-induced disso-
ciation and electron-transfer dissociation [3]. Twelve of
the 16 sites identified are novel in vitro autophosphor-
ylation sites, with two of these sites previously identi-
fied in vivo [3].
Experimental
QconCAT Design and Expression
Peptide sequences were selected for inclusion in the
QconCAT based on previously obtained LC-ESI-MS/
MS data [3]. One peptide was included for each site of
phosphorylation in addition to two peptides from a
region that could not be phosphorylated (i.e., no serine,
threonine, or tyrosine residues) or had never been
identified as being phosphorylated. Due to the presence
of missed cleavage peptides within the native protein
during the initial experiments, flanking sequences ei-
Scheme 1. Isotopically labeled internal standard protein (QconCAT
or KD Mps1) is added to the phosphorylated protein of interest
and digested with trypsin. Peptides incorporating a site of phos-
phorylation result show a reduced light/heavy ratio during MS
analysis, in comparison with sequences not incorporating a phos-
phorylation site. The extent of the discrepancy reveals the stoichi-
ometry of phosphorylation.ther side of the tryptic peptide were incorporated into
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four and 13 amino acid residues N-terminal to the
Q-peptide. Following completion of the QconCAT de-
sign, the gene vector was generated (Entelechon GmBH,
Regensburg, Germany).
The QconCAT protein and the “kinase-dead” (KD)
and, therefore, nonphosphorylated Mps1 protein [3]
were expressed in the presence of [13C6]R/K and puri-
fied as previously described [20].
Tryptic Digestion
To assess the stoichiometry of phosphorylation, a
known quantity of [13C6]-R/K KD Mps1 or [
13C6]-R/K
QconCAT was added to WT (wild type) Mps1 (highly
purified from E. coli). Proteins were reduced with
dithiothreitol at 5 mM at 60 °C for 15 min, alkylated
with 20 mM iodoacetamide at room temperature for 45
min, quenching excess iodoacetamide with dithiothrei-
tol to a final concentration of 10 mM. Proteins were
digested by addition of trypsin (2% (wt/wt)) at 37 °C
for 4 h. An additional dose of trypsin [2% (wt/wt)] was
added and digestion was completed at 37 °C for 18 h.
Peptide Desalting
Peptide samples were acidified by addition of formic
acid and desalted using C18 ZipTips (Millipore, Bil-
lerica, MA, USA), eluting with 80% (vol/vol) acetoni-
trile 0.1% (vol/vol) formic acid.
Phosphatase Treatment
Lambda phosphatase (1000 units) (New England Bio-
labs, Hertfordshire, UK) was added to 10 pmol of
digested phosphoprotein and was incubated at 30 °C
for 2 h in 50 L of 50 mM Tris-HCl, 100 mM NaCl, 0.1
mM EGTA, 2 mM dithiothreitol, and 20 mM MnCl2 at
pH 7.9. Ten units of calf intestinal alkaline phosphatase
(New England Biolabs, Hertfordshire, UK) were added
to 10 pmol of digested phosphoprotein. The mixture
was incubated at 30 °C for 1 h in 50 L 50 mM Tris-HCl,
Table 1. List of peptides incorporated into the QconCAT for de
peptides highlighted in bold were incorporated for the absolute q
incorporated as they had previously been identified as being pho
GGVNDNEEGFFSAR was incorporated as a reference for quantif
Protein Phosphorylation site(s) identified
Mps1 —
Mps1 —
Mps1 S582
Mps1 S742
Mps1 Y811, S821 & S824
Mps1 T564
Mps1 T795
Mps1 S682 & T686
Mps1 T675 & T676
Mps1 S533
Standard —100 mM NaCl, 0.1 mM EGTA, 1 mM dithiothreitol, 20
mM MnCl2, pH 7.5. Following phosphatase treatment,
peptides were desalted (as described above) before
mass spectrometric analysis.
Mass Spectrometric Analysis
Samples were analyzed by MALDI-TOF on an Ultraflex
II (Bruker, Coventry, UK) before LC-ESI-MS. Approxi-
mately 100 fmol of digested protein was co-crystallized
with 2,5-dihydroxybenzoic acid matrix (20 mg/mL in
50% (vol/vol) acetonitrile, 0.1% (vol/vol) formic acid).
For all LC-ESI-MS experiments, the digestion mixture
was acidified to 0.1% (vol/vol) formic acid, injected into
an Ultimate 3000 capillary LC system (Dionex, Camber-
ley, Surrey, UK) via a FAMOS autosampler, and sepa-
rated using a 75 m reverse-phase capillary column (15
cm) (LC Packings, Sunnyvale, CA, USA), at a flow rate
of 200 nL/min, in-line with nano-electrospray source of
a Q-TOF Global instrument (Waters, Manchester, UK).
Where LC-ESI-MS analyses were used for quantifica-
tion, ratios (light/heavy) were determined based on
extracted ion chromatograms (XICs) produced for each
peptide pair using QuanLynx (Waters). To ensure that
the correct peptides were quantified, MS/MS raw data
(from a separate LC-ESI-MS/MS analysis) were submit-
ted to MASCOT, and searched against a database
containing the QconCAT sequence for peptide identifi-
cation.
Results and Discussion
QconCAT Design
A QconCAT protein was designed to incorporate peptide
sequences that report on phosphorylated and nonphos-
phorylated tryptic peptides from five proteins including
Mps1. The Mps1 phosphorylated sites were identified
in previous qualitative analyses [3]. The design of this
QconCAT construct enabled the simultaneous production
of 40 peptides for the absolute quantification of the stoi-
chiometry of 32 sites of phosphorylation in four proteins;
nation of the stoichiometry of Mps1 phosphorylation sites. The
ification of the total protein. The peptides underlined were
rylated (sites identified are indicated). Peptide
n of the QconCAT
Sequence
GQTTKARFLYGENMPPQDAEIGYRNSLRQTNK
AVERGAVPLEMLEIALRNLNLQKKQLLSEEEK
YLNKLQQHSDKIIR
MTYGKTPFQQIINQISK
GTTEEMKYVLGQLVGLNSPNSILK
YAIKYVNLEEADNQTLDSYRNEIAYLNK
CCLKDPKQRISIPELLAHPYVQIQTHPVNQMAK
SVVKDSQVGTVNYMPPEAIK
GMLKLIDFGIANQMQPDTTSVVK
SILKQIGSGGSSKVFQVLNEKtermi
uant
spho
icatioGGVNDNEEGFFSAR
2214 JOHNSON ET AL. J Am Soc Mass Spectrom 2009, 20, 2211–2220ten of these are sites are located on Mps1 (Table 1). The
flanking sequences of these 40 tryptic peptides corre-
sponded to their contexts in the target proteins, thus
accounting for any potential missed cleavage (Table 1).
Wherever possible, sequences were ordered in the
QconCAT as in the native sequence. The QconCAT was
expressed in E. coli grown in minimal medium supple-
mented with [13C6]-analogues of arginine and lysine.
We also produced a His6-tagged form of the Mps1
mutant, incorporating a D664A substitution (where
amino acids are numbered based on the full length
sequence) in the catalytic domain, rendering the kinase
inactive (“kinase dead”, KD). The expressed proteins
were purified by virtue of their His6-tags and KD Mps1
was quantified using a standard Bradford protein as-
say. The QconCAT protein was quantified by MS us-
ing an additional tryptic peptide unrelated to the pro-
teins of interest and incorporated for this purpose
(GVNDNEEGFFSAR). Specifically, a digest of the QconCAT
protein was co-analyzed with a known quantity of
chemically synthesized GVNDNEEGF*FSAR (where *F
indicates [13C9,
15N1]-F) to allow determination of the
quantity of protein. A known quantity of chemically
synthesized GVNDNEEGF*FSAR was added with each
use of the QconCAT for quantitative analysis of WT
Mps1 protein by LC-ESI-MS. It is important to note here
that the sequence within the QconCAT contained an
additional glycine residue at the N-terminus. This has
previously been shown to have no effect on the re-
sponse factor when analyzed by electrospray ionization
(ESI) using a QTOF mass spectrometer [22]. This strat-
egy was employed to allow the absolute quantification
of numerous QconCATs simultaneously without the
requirement for differential isotopic labeling of each
QconCAT protein. Using this approach, the concentra-
tion of the QconCAT was determined as 130  19
fmol/l (coefficient of variation (CV) of 15%, n  5
preparations). The QconCAT protein was absolutely
quantified within the same experiment as used to
determine the stoichiometry of phosphorylation, allow-
ing also the absolute quantification of WT Mps1 as
148  38 fmol/L (n  4 preparations). Though the
QconCAT was designed for the study of several pro-
teins, only analyses of Mps1 are reported here, allowing
a focus on the alternative use of the stable isotope-
labeled nonphosphorylated Mps1.
Determination of the Stoichiometry of
Phosphorylation
The stable isotope labeled KD Mps1 or QconCAT was
added in known quantities to bacterially expressed
autophosphorylated Mps1 before tryptic digestion. The
digest was analyzed by matrix-assisted laser desorption
ionization (MALDI)-MS and LC-ESI MS. Two or more
reference peptides from unmodified regions of Mps1
were used to identify the ratios (unlabeled/labeled:
(L/H)ref) in which the two proteins (Mps1/KD Mps1 orMps1/QconCAT) were mixed, thus enabling absolute
quantification of Mps1. This use of multiple reference
peptides from nonphosphorylated regions and assess-
ment of any variation between the L/H ratios for these
peptides provides evidence for any unexpected modi-
fication of these sequences. Isotopic ratios ((L/H)mod)
were also determined for each of the tryptic peptides
incorporating phosphorylation sites, and the phosphor-
ylation stoichiometry calculated in each case using the
following equation:
Stoichiometry (%)
 100 100 ((L ⁄ H)mod ⁄ (L ⁄ H)ref)
To substantiate the effectiveness of tryptic digestion, we
co-analyzed isotope-labeled QconCAT and unlabeled
KD Mps 1 and demonstrated consistent L/H ratios for
all signature peptides (0.84  0.13; mean  CV, n  8,
the number of peptides analyzed). These experiments
were repeated six times resulting in instrumental CVs
of less than 3% for each peptide measured. Addition-
ally, the efficiency of tryptic digestion was also as-
sessed. A repeated dose of trypsin was added after 4 h
and then again after 18 h. The L/H ratio of [13C6]-R/K
labeled QconCAT or KD Mps1 to unlabelled wild-type
Mps1 was monitored and found not to change after the
second dose of trypsin (data not shown), thus indicat-
ing that tryptic digestion had been completed as effi-
ciently as possible.
Use of [13C6]-R/K labeled KD Mps1 for
Phosphorylation Determination
Figure 1a shows four regions of the MALDI-TOF mass
spectrum, corresponding to isotopic variants of one pep-
tide not incorporating a modification site (SIDPWER)
and three peptides incorporating sites of phosphoryla-
tion (TPFQQIINQISK, YVNLEEADNQTLDSYR, and
DSQVGTVNYMPPEAIK). The L/H ratios were deter-
mined from the summed areas of the first three peaks in
each isotope cluster, enabling calculation of the stoi-
chiometries of phosphorylation as 26%  4%, 53% 
1%, and 80%  1% for n  6 (where n  number of
instrumental repeats), respectively. For the peptide
DSQVGTVNYMPPEAIK, prior qualitative analyses [3]
indicated the presence of two phosphopeptide forms:
DSQVGpTVNYMPPEAIK and DpSQVGpTVNYMPPEAIK.
The quantitative analyses reported here demonstrate that
this sequence is either mono- or bis-phosphorylated
to 80%. As T686 is phosphorylated in both modified
forms of this peptide, these data indicate that the amino
acid T686 is phosphorylated with a stoichiometry of
80%. A similar situation arises with the peptide
YVLGQLVGLNSPNSILK, on which three sites of phos-
phorylation have previously been identified. How-
rey l
ectra
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(YVLGQLVGLNSPNpSILK) is modified in all phospho-
forms of this peptide, the stoichiometry of phosphory-
lation of S824 can be determined as 93% whilst the
Figure 1. Quantification of the stoichiometry of
analyzed by MALDI-TOF and LC-ESI-MS. (a)
performed using the summed areas of the isot
phosphorylation was calculated as described in th
lated peptide, whilst the other peptides exhibi
Underlined residues have been identified as pho
analyses. (b) Extracted ion chromatogram (XIC) of
of the labeled (H) (red line) and unlabeled (L) (g
DSQVGTVNYMPPEAIK (bottom). Partial mass spstoichiometry of sites S821 and Y811 remain unknown.Comparison of MALDI-MS and LC-ESI-MS
Quantification
Figure 1b exemplifies LC-ESI-MS data for two of
phorylation using isotopically labeled KD Mps1
ntification following MALDI-TOF analysis was
variants of each peptide. The stoichiometry of
. Peptide SIDPWER is a reference nonphosphory-
ecreased L/H ratio indicative of modification.
rylated. These data are representative of n  6
n corresponding to the doubly protonated species
ine) forms of YVNLEEADNQTLDSYR (top) and
corresponding to these XICs are inset.phos
Qua
opic
e text
t a d
spho
the iothese same peptides, YVNLEEADNQTLDSYR and
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chromatograms (XICs) for each peptide pair; L/H ratios
were determined from the areas under each chromato-
graphic peak. In each case, estimates of (L/H)ref, using
the [13C6]-R/K labeled KD Mps1, were based on deter-
minations of four nonphosphorylated peptides, includ-
ing SIDPWER; mean estimates were obtained with a
coefficient of variation of 9% and 13% from MALDI-
TOF MS and LC-ESI MS analyses, respectively. When
using the [13C6]-R/K labeled QconCAT, four nonphos-
phorylated peptides were used, including peptides
within the flanking regions (Table 1). Mps1 peptides
YVNLEEADNQpTLDSYR and DSQVGpTVNYMPPEAIK
were previously identified to be phosphorylated on
T564 and T686, respectively. Using the isotope-labeled
form of KD-Mps1, the stoichiometry of phosphorylation
was calculated to be 60% and 90% for these two
peptides. Table 2 shows a comparison of stoichiometry
data for eight phosphorylation sites, five of which were
determined by both MALDI-TOF MS and LC/ESI-MS.
However, MALDI-TOF MS could not be used to deter-
mine the stoichiometry of phosphorylation for three
peptides due to the presence of overlapping peptide
ions which prevented accurate calculation of peak ar-
eas; the two MS methods otherwise showed good
agreement within the limits of the observed precision.
Generally, the calculated stoichiometry of phosphory-
lation was marginally lower using the MALDI-TOF MS
data, which can be explained by the lack of peptide
chromatographic separation of the MALDI-TOF ana-
lyzed mixture, resulting in the presence of overlapping
species. The method incorporating coupled chromato-
graphic separation is therefore generally to be pre-
ferred, as this enables separation and thus accurate
quantification of peptide ions of similar m/z. An exam-
ple of this is the peptide TLYEHYSGGESHNSSSSK at
m/z 1969.85, where significant overlapping signals pre-
Table 2. Comparison of the stoichiometry of phosphorylation ca
MS and LC-ESI-MS. Each mass spectrometric experiment was pe
analysis for the percentage stoichiometry; the mean stoichiometry
Workflow Peptide sequence
LC-ESI-MS ISIPELLAHPYVQIQTHPVNQMAK
MALDI-MS ISIPELLAHPYVQIQTHPVNQMAK
LC-ESI-MS TPFQQIINQISK
MALDI-MS TPFQQIINQISK
LC-ESI-MS DSQVGTVNYMPPEAIK
MALDI-MS DSQVGTVNYMPPEAIK
LC-ESI-MS YVLGQLVGLNSPNSILK
MALDI-MS YVLGQLVGLNSPNSILK
LC-ESI-MS YVNLEEADNQTLDSYR
MALDI-MS YVNLEEADNQTLDSYR
LC-ESI-MS MASSSANECISVK
MALDI-MS MASSSANECISVK
LC-ESI-MS QHMDSPDLGTDDDDK
MALDI-MS QHMDSPDLGTDDDDK
LC-ESI-MS TLYEHYSGGESHNSSSSK
MALDI-MS TLYEHYSGGESHNSSSSKvented analysis by MALDI-TOF MS, but the extra
dimension of separation afforded by reversed-phase
chromatography permitted quantification (Figure 2).
Where no overlapping peptide ion signals are present,
the correlation between the stoichiometry of phosphor-
ylation obtained by MALDI-TOF MS analyses is in
accordance with LC-ESI-MS quantification. In all exper-
iments, the MALDI-TOF MS stoichiometry of phos-
phorylation calculations are within 11% of that for the
LC-ESI-MS analyses. Significantly, it is important to
note that the instrumental variation for both the
MALDI-TOF MS and LC-ESI MS analyses were consis-
tently below 5%.
Comparison of Determination of Phosphorylation
Stoichiometry Using [13C6]-R/K Labeled QconCAT
and KD Mps1
The stoichiometry data obtained using the [13C6]R/K-
labeled KD Mps1 and the QconCAT were also compared
(Figure 3 and Table 3) and demonstrated agreement
within 10%. Technical experimental variation was as-
sessed (n  6, where sample preparation and mass spec-
trometric analyses were independently carried out for
each replicate). At extreme L/H ratios, where either the
unlabeled or labeled ion is of relatively low signal inten-
sity, notably for the peptide LIDFGIANQMQPDTTSVVK,
the CVs were higher than those where the L/H ratios
were closer to unity (Table 3). The stoichiometry of phos-
phorylation was calculated for fewer peptides using the
QconCAT than the kinase dead Mps1 catalytic domain as
only selective Mps1 peptides were incorporated into the
QconCAT design (comparison of Tables 2 and 3).
Phosphorylation sites T676 (LIDFGIANQMQPDTpTS-
VVK) and T686 (DSQVGpTVNYMPPEAIK) have been
identified as sites crucial for the full catalytic activity of
ted using [13C6]-R/K labeled KD Mps1 analyzed by MALDI-ToF
ed six times to indicate the reproducibility of instrumental
coefficient of variation (CV) are included for each peptide
m/z
Phosphorylation determination
% Stoichiometry CV (%)
682.67 66 13.1
2727.55 63 8.3
708.92 34 30.5
1416.85 25 16.2
874.98 88 4.9
1748.94 80 1.4
908.00 95 2.0
1815.20 89 1.1
965.50 60 9.5
1929.98 53 2.5
692.36 82 6.8
1383.62 — —
563.58 66 29.7
1688.67 — —
657.29 99 0.4lcula
rform
and1969.85 — —
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detect any nonphosphorylated T676, while the stoichi-
ometry of phosphorylation of T686 was 95%  1%,
indicating that both sites are highly modified.
Assessment of the Influence of Missed Cleavages
All quantitative proteome analyses that employ peptide
internal standards (however derived) incorporate the
assumption that tryptic hydrolysis is fully effective; this
assumption must be tested. In the present work, tryptic
digestion of the phosphorylated protein may be differ-
entially affected by the phosphorylation. The signifi-
cance of missed cleavage was reduced by performing
digestion in two stages, corresponding to separate ad-
ditions of trypsin, separated by 4 h, with a total diges-
tion time of 22 h. Nevertheless, we identified one
miss-cleaved peptide consistently in our experim-
ents, namely YVNLEEADNQTLDSYRNEIAYLNK,
the full sequence of which was incorporated in the
QconCAT protein. We compared the L/H ratios of
the fully cleaved peptide YVNLEEADNQTLDSYR and
Figure 2. Mass spectra showing peptide TLYEHYSGGESHNSSSSK
and its labeled counterpart TLYEHYSGGESHNSSSSK* analyzed
by MALDI-TOF MS (top panel) and LC-ESI MS (bottom panel).
The monoisotopic masses of the labeled and unlabeled forms of
the peptide are indicated with arrows in both panels.YVNLEEADNQTLDSYRNEIAYLNK within the QconCATexperiments (Figure 4a and b) and the KD Mps1 exper-
iments (Figure 4c and d).
Within the QconCAT experiment, the L/H ratio
of YVNLEEADNQTLDSYR was 1.62  0.06 (n  6
replicate LC-MS analyses) whilst the L/H ratio for
YVNLEEADNQTLDSYRNEIAYLNK was 1.33  0.13
(n  6) (Figure 4a and b, respectively). The L/H ratios
for the fully cleaved and the miss-cleaved peptide were
0.85  0.01 and 1.00  0.03 within the KD Mps1
experiments (Figure 4c and d, respectively). This indi-
cates a modest difference of 15% between the two sets
of peptides (fully cleaved and miss-cleaved) within
both the QconCAT and the KD Mps1 experiments. The
difference of 15% in the KD Mps1 could indicate that
due to the presence of the phosphate these two popu-
lations of peptides are differentially represented. How-
ever, the difference in L/H ratio in the QconCAT
experiment could be due to the reduced signal-to-noise
of the miss cleaved peptide, which would give rise to
increased variation. This reduced presence of the miss-
cleaved peptide could be due to the significantly differ-
ent conformation of the QconCAT protein compared to
the native Mps1 structure. However, although clearly a
phosphate group has the potential to induce missed
cleavage it does not impair the determination of phos-
phorylation upon this peptide.
Assessment of Artifactual Modification of Tryptic
Peptides
The presence of artifactual modification can skew quan-
titative determinations if the extent of modification
differs between phosphorylated peptide and internal
standard. In the current experiments, a minor extent
(less than 5%) of methionine oxidation was observed; in
these instances, the observed L/H ratios for the modi-
fied peptide pairs were in agreement with those ob-
served for the unmodified peptides.
Analyses After Phosphatase Treatment
If the differences in L/H ratio between peptides incor-
porating a site of phosphorylation and those corre-
sponding to unmodified sequences are indeed entirely
attributable to phosphorylation, then prior treatment
with a phosphatase enzyme should in principle result in
the subsequent recording of a single, common L/H
ratio. In practice, this will be so only if phosphate
hydrolysis is complete. In the present work, additional
quantitative analyses were performed on wild type
Mps1 after treatment with either alkaline or lambda
phosphatase, using the labeled QconCAT or KD Mps1
as internal standard (Figure 5). In five of the eight
peptides for which we report data, phosphatase treat-
ment restored the L/H ratio to 0.9–1.0 of that observed
for the reference peptides (data not shown). For
DSQVGTVNYMPPEAIK (which contains T686), phos-
2218 JOHNSON ET AL. J Am Soc Mass Spectrom 2009, 20, 2211–2220phatase treatment increased the L/H ratio from 0.06 
0.002 to 1.03 0.01 (n  6 replicate LC-MS analyses)
after alkaline phosphatase treatment, compared with
2.43 0.38 (n 3, the number of peptides analyzed) for
the reference peptides, suggesting that phosphate hy-
drolysis was 45% complete for this peptide. Evaluation
of the LC-MS data for the sample after phosphatase
treatment, by examination of the extracted ion chro-
matogram corresponding to the phosphorylated pep-
tide, failed to detect this component (Figure 5), but this
may be attributable to limited detectability for
this phosphopeptide. Equivalent observations with
alkaline and  phosphatase was also made for both
Figure 3. Absolute quantification of phospho
standard protein and the QconCAT. XICs and m
L/H pair and phosphopeptide YVLGQLVGLN
identified as phosphorylated.
Table 3. The calculated phosphorylation stoichiometry for each
indicate the reproducibility evident from analyses of multiple (n
for LIDFGIANQMQPDTTSVVK using the kinase dead construct du
Workflow Peptide sequence
Kinase dead ISIPELLAHPYVQIQTHPVNQMAK
QconCAT ISIPELLAHPYVQIQTHPVNQMAK
Kinase dead TPFQQIINQISK
QconCAT TPFQQIINQISK
Kinase dead DSQVGTVNYMPPEAIK
QconCAT DSQVGTVNYMPPEAIK
Kinase dead YVLGQLVGLNSPNSILK
QconCAT YVLGQLVGLNSPNSILK
Kinase dead YVNLEEADNQTLDSYR
QconCAT YVNLEEADNQTLDSYR
Kinase dead LIDFGIANQMQPDTTSVVK
QconCAT LIDFGIANQMQPDTTSVVK 103LIDFGIANQMQPDTTSVVK and YVLGQLVGLNSPN-
SILK. These findings would be consistent with the
presence of modifications other than phosphorylation,
although other modifications are unlikely to occur
during bacterial protein expression. Close inspection of
the mass spectra revealed that the extents of methionine
oxidation and deamidation for these peptides were not
significantly altered after phosphatase treatment, which
could potentially account for the differences observed.
A more likely explanation, therefore, is that dephos-
phorylation is incomplete in these highly modified
peptides, reinforcing the notion that calculations of
stoichiometry based on comparative analyses before
ide stoichiometry using kinase dead internal
pectra (inset) of reference peptide VFQVLNEK
ILK L/H pair. Underlined residues have been
phorylated peptide, analyzed by LC-ESI-MS. The CV values
independent samples. Quantification could not be performed
he insertion of the single point mutation (D664A) in KD Mps 1
/z
L/H ratio
% StoichiometryMean CV (%)
2.67 0.493 6.3 58
2.66 0.335 0.6 66
8.92 0.600 3.4 39
8.81 0.606 9.3 45
4.98 0.111 14.8 88
4.90 0.168 3.5 95
8.00 0.041 10.6 95
7.95 0.121 8.8 91
5.50 0.404 24.1 56
5.33 0.463 16.6 60
— — —pept
ass s
SPNSphos
 6)
e to t
m
68
68
70
70
87
87
90
90
96
96
—
8.95 0.002 94.7 100
2219J Am Soc Mass Spectrom 2009, 20, 2211–2220 DETERMINATION OF PHOSPHORYLATION STOICHIOMETRYand after phosphatase treatment have a risk of signifi-
cant inaccuracy.
Conclusions
Stable isotope-labeled QconCAT and kinase dead pro-
tein have been utilized to determine the stoichiometry
of phosphorylation and the absolute amounts of the
catalytic domain of Mps1. Assessment by MALDI-TOF
MS and LC-ESI MS for the quantitative analysis of
phosphopeptide stoichiometry revealed a close agree-
ment in the absence of overlapping ion signals. Phos-
phatase treatment (both alkaline and  phosphatase)
confirmed the presence of phosphorylation on the pep-
tides selected. However, although the phosphopeptides
could not be observed after enzymatic treatment (pre-
sumably due to issues associated with their ionization
Figure 4. LC-ESI-MS mass spectra and extracte
YVNLEEADNQTLDSYRNEIAYLNK and the ful
corresponding labeled QconCAT or KD Mps1 m
[13C6]-R/K labeled QconCAT counterpart. (b) X
[13C6]-R/K labeled QconCAT counterpart. (c) X
labeled KD Mps1 counterpart. (d) XICs of YVN
labeled KD Mps1 counterpart. In all XICs, L re
peptide.and/or detection), this method could not be used foraccurate determination of phosphopeptide levels due to
incomplete phosphate removal. This should be kept in
mind when using a phosphatase treatment strategy for
calculating the stoichiometry of phosphorylation. The
QconCAT method provides a rigorous method for
concomitant absolute quantification of target proteins
and determination of the stoichiometry of phosphory-
lation at known sites. In principle, the application of this
approach can be extended to the quantification of other
post-translational modifications, assuming prior qua-
litative characterization. During preparation of this
manuscript, related strategies were described for calcu-
lating the stoichiometry of phosphorylation by Blair
and coworkers and by Steen and coworkers, using
isotope-labeled peptide and intact protein internal stan-
dards, respectively [11, 23]. The QconCAT approach
presented here, however, is uniquely capable of deter-
chromatograms (XICs) of miss-cleaved peptide
aved peptide YVNLEEADNQTLDSYR and their
s. (a) XICs of YVNLEEADNQTLDSYR and its
of YVNLEEADNQTLDSYRNEIAYLNK and its
of YVNLEEADNQTLDSYR and its [13C6]-R/K
ADNQTLDSYRNEIAYLNK and its [13C6]-R/K
to the unlabeled peptide and H to the labeledd ion
ly cle
asse
ICs
ICs
LEE
fersmining the absolute amounts of multiple proteins and
2220 JOHNSON ET AL. J Am Soc Mass Spectrom 2009, 20, 2211–2220the stoichiometry of their modifications in a single
experiment. Furthermore, whilst the data reported in
this paper relate to multiple sites of phosphorylation in
a single protein, the QconCAT was designed the enable
the study of multiple proteins, exemplifying a general
feature of this approach.
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